Skip to content
Triangle logo TriangleGet started
← Back to this collection

PUBLICATIONS · 30122620

Brentuximab vedotin with gemcitabine for paediatric and young adult patients with relapsed or refractory Hodgkin's lymphoma (AHOD1221): a Children's Oncology Group, multicentre single-arm, phase 1-2 trial.

Open original source → · Download preserved record

Bibliographic metadata only. No full-text article or abstract is reproduced. Absence of a captured notice is not confirmation that a publication is clear of corrections or retractions.

Journal
Lancet Oncol
Publication date
2018 Sep
First author
Cole PD

Publication notices

absence is not clearance
true
has correction metadata
false
has expression of concern metadata
false
has retraction in link
false
pubmed marks article retracted
false
pubmed marks retraction notice
false
relationships
  1. citation
    Lancet Oncol. 2018 Sep;19(9):1144-1146. doi: 10.1016/S1470-2045(18)30510-2.
    note
    Source null
    related pmid
    30122617
    relationship
    Comment in

Authors and identifiers

  1. name
    Cole PD
    type
    Author
  2. name
    McCarten KM
    type
    Author
  3. name
    Pei Q
    type
    Author
  4. name
    Spira M
    type
    Author
  5. name
    Metzger ML
    type
    Author
  6. name
    Drachtman RA
    type
    Author
  7. name
    Horton TM
    type
    Author
  8. name
    Bush R
    type
    Author
  9. name
    Blaney SM
    type
    Author
  10. name
    Weigel BJ
    type
    Author
  11. name
    Kelly KM
    type
    Author
Complete bibliographic record and source provenance
authors
  1. name
    Cole PD
    type
    Author
  2. name
    McCarten KM
    type
    Author
  3. name
    Pei Q
    type
    Author
  4. name
    Spira M
    type
    Author
  5. name
    Metzger ML
    type
    Author
  6. name
    Drachtman RA
    type
    Author
  7. name
    Horton TM
    type
    Author
  8. name
    Bush R
    type
    Author
  9. name
    Blaney SM
    type
    Author
  10. name
    Weigel BJ
    type
    Author
  11. name
    Kelly KM
    type
    Author
bibliography ids
  1. nci-bib-cb4a19cce56c5f0bcfb3c328
book metadata
content sha256
d18ec8f42390949f2ebf392c977b3ed5e2706509825811c2188aef0b7702f463
document type
citation
dois
  1. 10.1016/S1470-2045(18)30426-1
electronic publication date
display
2018 Aug 16
precision
day
year
2018
evidence scope
bibliographic_metadata_only
id
pubmed:30122620
immutable id
pubmed:30122620@d18ec8f42390949f2ebf392c977b3ed5e2706509825811c2188aef0b7702f463
journal
abbreviation
Lancet Oncol
issn electronic
1474-5488
issn print
1470-2045
issue
9
name
The Lancet. Oncology
nlm unique id
100957246
pages
1229-1238
volume
19
languages
  1. eng
notices
absence is not clearance
true
has correction metadata
false
has expression of concern metadata
false
has retraction in link
false
pubmed marks article retracted
false
pubmed marks retraction notice
false
relationships
  1. citation
    Lancet Oncol. 2018 Sep;19(9):1144-1146. doi: 10.1016/S1470-2045(18)30510-2.
    note
    Source null
    related pmid
    30122617
    relationship
    Comment in
outcomes validated
false
pmid
30122620
provenance
batch id
438b2803888025c6cf56
provider
NCBI PubMed ESummary
record sha256
e63557c20b825c2ff8c279a315a991189ec012cb664a1ce2a418a78e676c961d
response sha256
0adf5ff07d3aa03a45feef5e4b7998e2ddea370eb9d1c6aa9134c5fd329767e6
retrieved at
2026-09-09T23:47:36.359220+00:00
publication date
display
2018 Sep
precision
month
year
2018
publication types
  1. Clinical Trial, Phase I
  2. Clinical Trial, Phase II
  3. Journal Article
  4. Multicenter Study
  5. Research Support, N.I.H., Extramural
  6. Research Support, Non-U.S. Gov't
record status
PubMed - indexed for MEDLINE
schema version
1.0
source url
https://pubmed.ncbi.nlm.nih.gov/30122620/
title
Brentuximab vedotin with gemcitabine for paediatric and young adult patients with relapsed or refractory Hodgkin's lymphoma (AHOD1221): a Children's Oncology Group, multicentre single-arm, phase 1-2 trial.

Preserved source evidence · Not medical advice